Page 12 - Epic Sciences News Today

3.3.2 Bioinformatics Plays a Role 3.4 Diagnostic Technology Development 3.4.2 Impact of NGS on pricing 3.4.3 Pharmacogenomics Blurs Diagnosis and Treatment 3.4.4 CGES Testing, A Brave New World 3.4.5 Biochips/Giant magnetoresistance based assay 4. Liquid Biopsy Recent Developments 4.1 Recent Developments - Importance and How to Use This Section 4.1.1 Importance of These Developments 4.1.2 How to Use This Section Liquid Biopsy NGS Panels - Diverse Test Claims CMS Colon Cancer Screening Me...

Liquid Biopsy Markets, 2025 with Impact of COVID-19 Pandemic February 02, 2021 04:43 ET | Source: Research and Markets Research and Markets Dublin, IRELAND ResearchAndMarkets.coms offering. The report includes detailed breakouts for 15 Countries and 4 Regions along with breakouts for Lung, Breast, Colorectal, Prostate, Cervical, and Other Cancers as well as breakouts by Screening/Early Detection, Diagnostic, Therapy Monitoring and Recurrence Monitor...

4.3.2 Shifting Role of Diagnostics 4.3.3 Multiplexing and Foundation One 4.3.4 The Disruption Dynamic 4.3.6 The Next Five Years 5. Cancer Immuno-Oncology Diagnostics Recent Developments 5.1 Recent Developments - Importance and How to Use This Section 5.1.1 Importance of These Developments 5.1.2 How to Use This Section Qiagen Expands Immuno-Oncology Portfolio IncellDx Awarded PD-L1 Detection Patent FDA Approves CDx for Trastuzumab Promega Nabs CE Mark for Microsatellite Instability IVD ...

Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market 2020 Trends, Business Opportunities, Future Demand and Forecast 2025

Anatomic Pathology Market: Historical, Current and Projected Market Size, Competitive landscape & Forecast 2022

Exact Sciences Announces Preliminary Fourth Quarter 2020 Results - Expected total revenue of $464.5-467.5M, including Screening revenue of $249-250M, Precision Oncology revenue of $117-118M, and COVID-19 testing revenue of $98.5-99.5M News provided by Share this article Share this article MADISON, Wis., Jan. 10, 2021 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company expects to report revenue between $464.5 million and $467.5 million for the fourth quarter ende...

4.1 Recent Developments - Importance and How to Use This Section 4.1.1 Importance of These Developments 4.1.2 How to Use This Section Genetron Health Targeting Early Cancer Detection Pan-European Initiative to Build Tools for Sharing Genomic Data UK Government Unveils New Genomic Healthcare Strategy Foundation Medicine Liquid Biopsy Gets FDA Approval American Heart Association Develops Genetic Testing Guidelines Yourgene Health Gets CE Mark for Iona NIPT Test NorthShore Looks to Expand ...

World Whole Genome and Exome Sequencing Markets, 2021-2025: COVID-19 Drives Overnight Global Growth in Pathogen Sequencing - A New Industry Emerges. December 16, 2020 10:43 ET | Source: Research and Markets Research and Markets Dublin, IRELAND ResearchAndMarkets.coms offering. The COVID Pandemic has created a surge in Whole Genome Sequencing of Pathogens but cancer-related activity has suffered. Find out all about it in the comprehensive report of W...

World Human Gene Sequencing Markets, Strategies & Trends Report 2021-2025: A Crowded, Growing Global Market with Complicated Packaging and Pricing is Emerging with Unlimited Growth Opportunities December 15, 2020 04:53 ET | Source: Research and Markets Research and Markets Dublin, IRELAND ResearchAndMarkets.coms offering. Will all newborns receive genetic testing at birth? Is COVID-19 holding the industry back? Where are the over 800 locations that ...

New Data at SABCS 2020 Highlight the Role of the Oncotype DX Breast Recurrence Score® Test in Shaping Clinical Practice - Five-year outcomes from large, prospective phase III ADAPT study confirm value of the test to help guide treatment decisions in breast cancer patients with high clinical risk, including those with node-positive disease - New meta-analysis of data from more than 10,000 patients with node-negative disease, including the results of TAILORx, supports the Oncotype DX Breast Recu...